Works matching DE "VIRAL vaccines"


Results: 4225
    1

    Announcements.

    Published in:
    Oncology (08909091), 2007, v. 21, n. 5, p. 618
    Publication type:
    Article
    2

    Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design.

    Published in:
    Nature Structural & Molecular Biology, 2015, v. 22, n. 10, p. 788, doi. 10.1038/nsmb.3096
    By:
    • Kotecha, Abhay;
    • Seago, Julian;
    • Scott, Katherine;
    • Burman, Alison;
    • Loureiro, Silvia;
    • Ren, Jingshan;
    • Porta, Claudine;
    • Ginn, Helen M;
    • Jackson, Terry;
    • Perez-Martin, Eva;
    • Siebert, C Alistair;
    • Paul, Guntram;
    • Huiskonen, Juha T;
    • Jones, Ian M;
    • Esnouf, Robert M;
    • Fry, Elizabeth E;
    • Maree, Francois F;
    • Charleston, Bryan;
    • Stuart, David I
    Publication type:
    Article
    3
    4
    5
    6

    Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillance.

    Published in:
    PLoS Biology, 2024, v. 22, n. 11, p. 1, doi. 10.1371/journal.pbio.3002916
    By:
    • Dadonaite, Bernadeta;
    • Ahn, Jenny J.;
    • Ort, Jordan T.;
    • Yu, Jin;
    • Furey, Colleen;
    • Dosey, Annie;
    • Hannon, William W.;
    • Vincent Baker, Amy L.;
    • Webby, Richard J.;
    • King, Neil P.;
    • Liu, Yan;
    • Hensley, Scott E.;
    • Peacock, Thomas P.;
    • Moncla, Louise H.;
    • Bloom, Jesse D.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.

    Published in:
    Nature, 2015, v. 519, n. 7543, p. 366, doi. 10.1038/nature14320
    By:
    • Mitchell, Duane A.;
    • Batich, Kristen A.;
    • Gunn, Michael D.;
    • Huang, Min-Nung;
    • Sanchez-Perez, Luis;
    • Nair, Smita K.;
    • Congdon, Kendra L.;
    • Reap, Elizabeth A.;
    • Archer, Gary E.;
    • Desjardins, Annick;
    • Friedman, Allan H.;
    • Friedman, Henry S.;
    • Herndon II, James E.;
    • Coan, April;
    • McLendon, Roger E.;
    • Reardon, David A.;
    • Vredenburgh, James J.;
    • Bigner, Darell D.;
    • Sampson, John H.
    Publication type:
    Article
    29
    30

    Vaccines: A moving target.

    Published in:
    Nature, 2011, v. 474, n. 7350, p. S16, doi. 10.1038/474S16a
    By:
    • Eisenstein, Michael
    Publication type:
    Article
    31
    32
    33
    34

    ЖИЗНЕСПОСОБНОСТЬ ШТАММОВ ОРТОПОКСВИРУСОВ ПРИ ПОДБОРЕ СТАБИЛИЗАТОРА ДЛЯ ЛИОФИЛИЗАЦИИ, ХРАНЕНИЯ И ТРАНСПОРТИРОВКЕ.

    Published in:
    Eurasian Journal of Applied Biotechnology, 2024, n. 3, p. 217, doi. 10.11134/btp.3.2024.23
    By:
    • А. Б., Алиева;
    • Д. Б., Айдарбекова;
    • К. Б., Баракбаев;
    • Е. К., Алмас;
    • О. Н., Серикбайов;
    • М. К., Кенжебаева;
    • Ш. Т., Табыс;
    • А. К., Наханов;
    • К. Д., Жугунисов
    Publication type:
    Article
    35

    IMUNIDADE CRUZADA FRENTE À INFECÇÃO DA COVID-19.

    Published in:
    Revista Foco (Interdisciplinary Studies Journal), 2023, v. 16, n. 9, p. 1, doi. 10.54751/revistafoco.v16n9-050
    By:
    • Belfort Piantino Faria, Camila;
    • Botelho Chaves, Matheus Felipe;
    • Oliveira Cardoso de Sá, Stephanie;
    • Freitas das Neves Gonçalves, Priscila;
    • Messias Ribeiro, Maxwell
    Publication type:
    Article
    36
    37
    38
    39
    40
    41

    Research Highlights.

    Published in:
    Nature Immunology, 2011, v. 12, n. 6, p. 518, doi. 10.1038/ni0611-518
    Publication type:
    Article
    42
    43

    HIV vaccine design: insights from live attenuated SIV vaccines.

    Published in:
    Nature Immunology, 2006, v. 7, n. 1, p. 19, doi. 10.1038/ni1296
    By:
    • Koff, Wayne C.;
    • Johnson, Philip R.;
    • Watkins, David I.;
    • Burton, Dennis R.;
    • Lifson, Jeffrey D.;
    • Hasenkrug, Kim J.;
    • McDermott, Adrian B.;
    • Schultz, Alan;
    • Zamb, Timothy J.;
    • Boyle, Rosanne;
    • Desrosiers, Ronald C.
    Publication type:
    Article
    44
    45
    46
    47
    48
    49

    Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4<sup>+</sup> T cell responses that impair CD8<sup>+</sup> T cell function.

    Published in:
    Science Immunology, 2016, v. 1, n. 5, p. 1, doi. 10.1126/sciimmunol.aaf7643
    By:
    • Larocca, Rafael A.;
    • Provine, Nicholas M.;
    • Aid, Malika;
    • Iampietro, M. Justin;
    • Borducchi, Erica N.;
    • Badamchi-Zadeh, Alexander;
    • Abbink, Peter;
    • Ng'ang'a, David;
    • Bricault, Christine A.;
    • Blass, Eryn;
    • Penaloza-MacMaster, Pablo;
    • Stephenson, Kathryn E.;
    • Barouch, Dan H.
    Publication type:
    Article
    50